Completed PHASE3 INTERVENTIONAL 4-arm NCT00852371

Intermittent Preventive Treatment of Malaria in Schoolchildren

IPT in Schoolchildren: Comparison of the Efficacy, Safety, and Tolerability of Antimalarial Regimens in Uganda

Sponsor: London School of Hygiene and Tropical Medicine

Conditions Intermittent Preventive Treatment Malaria

Interventions Placebo amodiaquine + sulfadoxine-pyrimethamine dihydroartemisinin-piperaquine sulfadoxine-pyrimethamine

Updated 8 times since 2017 Last updated: Mar 19, 2024 Started: Feb 29, 2008 Primary completion: Jun 30, 2008 Completion: Jun 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00852371, this PHASE3 trial focuses on Intermittent Preventive Treatment and Malaria and remains completed. Sponsored by London School of Hygiene and Tropical Medicine, it has been updated 8 times since 2008, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Apr 2024 — Jul 2024 [monthly]

Completed PHASE3
Jan 2021 — Apr 2024 [monthly]

Completed PHASE3
Sep 2020 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 3 earlier versions

Jun 2018 — Sep 2020 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Feb 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

London School of Hygiene and Tropical Medicine
Ministry of Health, Uganda
Uganda Malaria Surveillance Project

Data source: London School of Hygiene and Tropical Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.